Zobrazeno 1 - 4 of 4 pro vyhledávání: '"Tratamiento de última línea"'
1
A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients
Autor: Elez, Elena, Pericay, Carles, Valladares-Ayerbes, Manuel, Bando, Inmaculada, Safont, Maria Jose, Gallego, Javier, Grávalos, Cristina, Arrivi, Antonio, Carrato, Alfredo, Conde, Verónica, Ortiz, Maria José, López, Carlos, Alonso, Beatriz, Ruiz de Mena, Inmaculada, Díaz-Rubio, Eduardo, Tabernero, Josep, Aranda, Enrique, Universitat Autònoma de Barcelona
Publikováno v: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
British Journal of Cancer
BACKGROUND: Targeted agents are standard treatment for RAS wild-type metastatic colorectal cancer in the first- and second-line settings. This phase 2 study determined the benefit of targeting the epidermal growth factor receptor (EGFR) with panitumu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::068001b4d36d161525fefa9dd7e823b6
https://hdl.handle.net/10668/14342
Zobrazit plný text záznamu
2
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial
Autor: Penalver, Francisco-Javier, Marquez, Jose-Antonio, Duran, Soledad, Giraldo, Pilar, Martin, Alejandro, Montalban, Carlos, Sancho, Juan-Manuel, Ramirez, Maria-Jose, Terol, Maria-Jose, Capote, Francisco-Javier, Gutierrez, Antonio, Sanchez, Blanca, Lopez, Andres, Salar, Antonio, Rodriguez-Caravaca, Gil, Canales, Miguel, Caballero, Maria-Dolores, Bello Lopez, Jose Luis, Carbonell, Felix, Ferrer Bordas, Secundino, Font Lopez, Patricia, Perez Persona, Ernesto, Lopez Guillermo, Armando, Hernandez Martin, Roberto, Ramon Mayans, Jose, Palomera, Luis, Perez Ceballos, Elena, Queizan Hernandez, Jose Antonio, Riaza Grau, Rosalia, de la Cruz, Fatima, Sanchez Salinas, Andres, GELTAMO Spanish Lymphoma Cooperati
Publikováno v: Cancer medicine
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Cancer Medicine. 2019;00:1–13.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
instname
Scientia
Cancer Medicine
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Cancer Medicine, Vol 8, Iss 16, Pp 6955-6966 (2019)
Background Consensus is lacking regarding the optimal salvage therapy for patients with follicular lymphoma who relapse after or are refractory to immunochemotherapy. Methods This phase II trial evaluated the efficacy and safety of response‐adapted
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b016266cc0c27999365889288230dbc8
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7284
Zobrazit plný text záznamu
4
Alemtuzumab as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease: Results of a Phase II Study
Autor: Martinez, Carmen, Solano, Carlos, Ferra, Christelle, Sampol, Antonio, Valcarcel, David, Antonio Perez-Simon, Jose, Spanish Grp Stem Cell Transplantat
Publikováno v: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
We conducted a phase II trial to investigate the safety and efficacy of alemtuzumab in treating steroid-refractory acute graft-versus-host disease (aGVHD) grade II or higher after stem cell transplantation. Ten adult patients (6 with aGVHD grade III
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e8665b9f8e1abdcb0d62b7d9f0b56ee
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje